Sapna R. Srivastava
Director/Board Member en INNOVIVA, INC. .
Fortuna: 1 M $ al 30/06/2023
Origen de la red de primer grado Sapna R. Srivastava.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis.
409
| Subsidiary | Financial Conglomerates | 409 |
Thomas Weisel Partners LLC
 Thomas Weisel Partners LLC Investment Banks/BrokersFinance Founded in 1998, Thomas Weisel Partners (TWP) is a broker/dealer headquartered in San Francisco with offices in New York City, Boston, Denver, Colorado and Palo Alto, California. The firm is a subsidiary of Thomas Weisel Partners Group, Inc. (Nasdaq: TWPG), a San Francisco-based investment banking firm. Their ultimate parent is Stifel Financial Corp. (NYSE: SF). TWP's investment banking, brokerage and equity research divisions serve emerging growth companies and institutional investors around the world. They are a member of the NYSE, the SIPC and FINRA. TWP specializes in the growth sectors of the economy with a particular focus on the consumer, energy, healthcare, Internet, media/telecommunications, metals/mining and technology sectors. Within the consumer sector, the firm focuses on: financial products, gaming/lodging, interactive market services, lifestyles/sports retailers, restaurants and hardlines and softlines retailing. TWP's global energy research is provided by analysts in three countries and covers the following trends: (1) fast-growing oil and natural gas producers in North America and worldwide (2) domestic and international energy service companies and (3) alternative energy technology and resource developers. Within the healthcare sector, TWP focuses on: biotechnology, diagnostics, healthcare information technology, pharmaceutical services, life science technology, medical devices and specialty pharmaceuticals. The firm's interest in the Internet, media and telecommunications sector include: Internet services, media, broadcasting and telecommunications services. Their focus within the metals and mining sector include: base metals, gold, precious metals and uranium. TWP's technology research focuses on: (1) applied technologies (2) communications components (3) core and wireless communications equipment (4) IP networking communications equipment (5) electronic supply chain (6) enterprise hardware (7) information and financial technology services (8) semiconductor capital equipment (9) broadline and specialty semiconductors (10) applications and communications software and (11) infrastructure software. TWP also provides value-added equities analysis across a variety of sectors including: industrials, financials, consumer, technology and healthcare.
63
| Extinct | Investment Banks/Brokers | 63 |
| Public Company | Biotechnology | 28 | |
| Public Company | Biotechnology | 25 | |
| Extinct | Medical Specialties | 20 | |
| Public Company | Biotechnology | 18 | |
AsclepiX Therapeutics LLC
 AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD.
10
| Holding Company | Miscellaneous Commercial Services | 10 |
| Extinct | Pharmaceuticals: Major | 9 | |
| Public Company | Pharmaceuticals: Major | 9 | |
| Private Company | Financial Conglomerates | 9 | |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a precision medicines company called Esker that aims to provide personalized treatments for people with autoimmune diseases. The company is based in San Francisco, CA. Esker uses a precision analytics platform, powered by foresite labs, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology to create medicines that change the lives of people with autoimmune disease. The company was founded by June H Lee. Martin Babler has been the CEO of the company since 2021.
8
| Holding Company | Pharmaceuticals: Major | 8 |
| Public Company | Biotechnology | 7 | |
Abide Therapeutics, Inc.
 Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA.
3
| Subsidiary | Pharmaceuticals: Other | 3 |
| Public Company | Financial Conglomerates | 2 | |
VelosBio, Inc.
 VelosBio, Inc. Miscellaneous Commercial ServicesCommercial Services VelosBio, Inc. operates as an biopharmaceutical company. It developes antibody-drug conjugates to treat hematological cancers and solid tumors. The company was founded in 2017 and is headquartered in San Diego, CA.
2
| Extinct | Miscellaneous Commercial Services | 2 |
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.
1
| Holding Company | Miscellaneous Commercial Services | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Sapna R. Srivastava a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Sales & Marketing | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing Corporate Officer/Principal Human Resources Officer | |
| Rochester Christian University | College/University | Director/Board Member Undergraduate Degree | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Chairman Director/Board Member | |
| MERSANA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member | |
| OCULAR THERAPEUTIX, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Undergraduate Degree Graduate Degree Masters Business Admin Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
| Stanford University | College/University | Masters Business Admin Undergraduate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| Vanderbilt University | College/University | Undergraduate Degree Graduate Degree | |
| University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Doctorate Degree | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Founder Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Graduate Degree Graduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| Boston College | College/University | Masters Business Admin Undergraduate Degree Doctorate Degree Masters Business Admin Graduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin Undergraduate Degree Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| GLEACHER & COMPANY INC | Investment Managers | Director/Board Member Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree | |
Harvard Stem Cell Institute
 Harvard Stem Cell Institute BiotechnologyHealth Technology Harvard Stem Cell Institute provides research regarding stem cells necessary for the understanding of human development and disease and trains next generation stem cell scientists. The company was founded by Doug A. Melton and David T. Scadden in April 2004 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| FRACTYL HEALTH, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Perelman School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
| Harvard Law School | College/University | Graduate Degree Doctorate Degree | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
Revolo Biotherapeutics Ltd.
 Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Palleon Pharmaceuticals, Inc.
 Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Director/Board Member Director/Board Member | |
| 89BIO, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ARMATA PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
| ZENTALIS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chairman | |
| E.MERGE TECHNOLOGY ACQUISITION CORP. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| EPIPHANY TECHNOLOGY ACQUISITION CORP. | Financial Conglomerates | Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member Corporate Officer/Principal Chief Executive Officer | |
| ENTERPRISE 4.0 TECHNOLOGY ACQUISITION CORP. | Financial Conglomerates | Chief Executive Officer Director/Board Member Director/Board Member Chief Executive Officer Chief Executive Officer Director/Board Member | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Private Equity Investor Corporate Officer/Principal | |
Tourmaline Bio, Inc.
 Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tourmaline Bio, Inc., Tourmaline Sub, Inc. is a late-stage clinical biotechnology company based in New York, NY. The private company's lead program, Tour006, is an anti-IL-6 antibody with high binding affinity and a naturally long half-life. Tour006 has been studied in over 400 autoimmune patients across six clinical trials. Tourmaline Sub plans to develop Tour006 for thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD), with additional indications being considered. The company, founded in 2021 by Sandeep Kulkarni and Caley M. Castelein, is focused on developing transformative medicines for patients with life-altering immune diseases. Sandeep Kulkarni has been the CEO since 2021. Tourmaline Sub was acquired by Talaris Therapeutics, Inc. on October 19, 2023, for $43.50 million. | Miscellaneous Commercial Services | General Counsel Founder Director of Finance/CFO | |
Endeavor Acquisition Corp. (Cayman Islands)
 Endeavor Acquisition Corp. (Cayman Islands) Financial ConglomeratesFinance Endeavor Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 19, 2021 and is headquartered in New York, NY. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| SARISSA CAPITAL ACQUISITION CORP. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| CARNEY TECHNOLOGY ACQUISITION CORP. II | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal |
Estadísticas
Internacional
| Estados Unidos | 48 |
| Irlanda | 2 |
| Francia | 2 |
| Reino Unido | 2 |
Sectorial
| Health Technology | 20 |
| Consumer Services | 19 |
| Finance | 11 |
| Commercial Services | 4 |
Operativa
| Director/Board Member | 477 |
| Corporate Officer/Principal | 210 |
| Independent Dir/Board Member | 169 |
| Chairman | 91 |
| Undergraduate Degree | 85 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Raj Bhikhu Parekh | 50 |
| Amy Schulman | 45 |
| Perry Karsen | 38 |
| George Bickerstaff | 37 |
| Peter Diamandis | 36 |
| Louis Lange | 35 |
| Alex Serge Vieux | 32 |
| Patrick Volkert Vink | 30 |
| Steven Altschuler | 27 |
| Jules Haimovitz | 27 |
| Stephen Sherwin | 26 |
| Ross Haghighat | 26 |
| Ronald Eastman | 24 |
| Scott Requadt | 23 |
| Christopher R. Pechock | 22 |
- Bolsa de valores
- Insiders
- Sapna R. Srivastava
- Conexiones Empresas
